Your browser doesn't support javascript.
loading
[Successful treatment of relapse/refractory multiple myeloma with carfilzomib, lenalidomide, and dexamethasone combination therapy following allogeneic bone marrow transplantation].
Fuchida, Shin-Ichi; Shimura, Kazuho; Taminishi-Katsuragawa, Yoko; Matsui-Maegawa, Saori; Okano, Akira; Hatsuse, Mayumi; Murakami, Satoshi; Shimazaki, Chihiro.
Afiliação
  • Fuchida SI; Department of Hematology, JCHO Kyoto Kuramaguchi Medical Center.
  • Shimura K; Department of Hematology, Aiseikai Yamashina Hospital.
  • Taminishi-Katsuragawa Y; Department of Hematology, JCHO Kyoto Kuramaguchi Medical Center.
  • Matsui-Maegawa S; Department of Hematology, JCHO Kyoto Kuramaguchi Medical Center.
  • Okano A; Department of Hematology, JCHO Kyoto Kuramaguchi Medical Center.
  • Hatsuse M; Department of Hematology, Omihachiman Community Medical Center.
  • Murakami S; Department of Hematology, JCHO Kyoto Kuramaguchi Medical Center.
  • Shimazaki C; Department of Hematology, JCHO Kyoto Kuramaguchi Medical Center.
Rinsho Ketsueki ; 60(10): 1468-1470, 2019.
Article em Ja | MEDLINE | ID: mdl-31695009

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Transplante de Células-Tronco Hematopoéticas / Lenalidomida / Mieloma Múltiplo Limite: Humans / Male / Middle aged Idioma: Ja Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Transplante de Células-Tronco Hematopoéticas / Lenalidomida / Mieloma Múltiplo Limite: Humans / Male / Middle aged Idioma: Ja Ano de publicação: 2019 Tipo de documento: Article